Name: Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem Diabody)
SKU: T-BSDB-158
Rating: 5 (1 reviews)

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can be used in immunoassay of Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors.

Datasheet INQUIRY

Specifications

Targets

EGFR & ZnO

Type

Tandem Diabody

Species Reactivity

Human

Application

Immunoassay

Related Disease

Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

EGFR

Gene ID

1956

UniProt ID

P00533

Alternative Names

EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog

Target 2

ZnO

Alternative Names

ZnO; Zinc oxide

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem Diabody) (T-BSDB-158). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-158)

Specifications

Targets

Customer Reviews and Q&As